Jan. 2 (Bloomberg) — IMS Health Holdings Inc., the health care focused information technology company taken private four years ago, filed for a $100 million initial public offering.
The figure is a placeholder used to calculate fees and may change. IMS, backed by Canada Pension Plan Investment Board, TPG Capital and Leonard Green & Partners LP, plans to use the funds for a proposed debt refinancing, according to today's regulatory filing. JPMorgan Chase & Co., Goldman Sachs Group Inc. and Morgan Stanley are managing the IPO.
IMS, which provides prescription data to drugmakers and analysts, posted $1.9 billion in revenue for the first nine months of 2013, with operating margins of 15 percent, according to the filing. The Danbury, Connecticut-based company was said to be considering an IPO as well as a sale process as of last month, possibly seeking a valuation of at least $8 billion, according to people familiar with the situation.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
